EVALUATION OF ANTIBIOTIC SUSCEPTIBILITY OF ANAEROBIC PATHOGENS BACTEROIDES, PREVOTELLA AND FUSOBACTERIUM ISOLATED FROM CANCER PATIENTS
Abstract
In this study 122 strains of strictly anaerobic gram-negative rods Bacteroides, Prevotella and Fusobacterium, isolated from cancer patients between 2004 and 2014 were analyzed. The most common strains were B. fragilis (55 %) followed by Prevotella (34.4 %) and Fusobacterium spp (10.6 %). The species identification was carried out by matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS). Among the B. fragilis group strains, B. fragilis, B. thetaiotaomicron, B. ovatus and B. vulgatus were isolated most frequently. Among Prevotella species, the most frequently isolated species were P. buccae, P. buccalis, P. oris, P. denticola and P. nigrescens, and 77 % of the Fusobacterium spp. were F. nucleatum. Susceptibilities of the isolates to antimicrobial agents were determined by the E-test methodology. The percentage of the susceptibility of B. fragilis group isolates were: metronidazole, 97 %; imipenem, 95.5 %; amoxicillin/clavulanate, 95.5 % and clindamycin, 77.6 %. Three B. fragilis isolates proved to be multidrug-resistant (simultaneously to imipenem, amoxicillin/ clavulanate and metronidazole or clindamycin). All Prevotella isolates were susceptible to imipenem and amoxicillin/clavulanate, whereas 78.6 % of the pigmented Prevotella species and 46.4 % of the non-pigmented species were resistant to penicillin. The number of strains susceptibility to metronidazole and clindamycin were 93 % and 88 %, respectively. All Fusobacterium strains were sensitive to all tested antibiotics, including penicillin.
About the Authors
I. I. Shilnikova
N.N. Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Shilnikova Irina Ivanovna, PhD, Senior Researcher of Laboratory for Microbiologic Diagnosis and Treatment of Infection in Oncology.
Phone: +7 (967) 084-76-70. E-mail: iish54@ mail.ru. SPIN-code: 9400-6222
N. V. Dmitrieva
N.N. Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Dmitrieva Natalia Vladimirovna, MD, DSc, Professor, Head of Laboratory for Microbiologic Diagnosis and Treatment of Infection in Oncology.
Phone: +7 (499) 324-18-40. E-mail: prof. ndmitrieva@mail.ru
References
1. Alauzet C., Mory F., Teyssier C., Hallage H., Carlier J.P., Grollier G., Lozniewski A. Metronidazole resistance in Prevotella spp. and description of a new nim gene in Prevotella baroniae // Antimicrob. Agents Chem. 2010. Vol. 54 (1). P. 60–64. doi: 10.1128/AAC.01003-09.
2. Aldridge K.E., Ashcraft D., Cambre K., Pierson C.L., Jenkins S.G., Rosenblatt J.E. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas and Peptostreptococcus species // Antimicrob. Agents Chemother. 2001. Vol. 45 (4). P. 1238–1243.
3. Betriu C., Culebras E., Gomez M., Lopez F., Rodriguez-Avial I., Picazo J.J. Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain // Antimicrob. Agents Chemother. 2008. Vol. 52 (7). P. 2686–2690. doi: 10.1128/AAC.0008108.
4. Boyanova L., Kolarov R., Gergova G., Dimitrova L., Mitov I. Trends in antibiotic resistance in Prevotella species from patients of the University Hospital of Maxillofacial Surgery, Sofia, Bulgaria, in 2003–2009 // Anaerobe. 2010. Vol. 16 (5). P. 489–492. doi: 10.1016/j.anaerobe.2010.07.004.
5. Huggan P.J., Murdoch D.R. Fusobacterial infections: clinical spectrum and incidence of invasive disease // J. Infect. 2008. Vol. 57 (4). P. 283–289. doi: 10.1016/j.jinf.2008.07.016.
6. Karlowsky J.A., Walkty A.J., Adam H.J., Baxter M.R., Hoban D.J., Zhanel G.G. Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010–2011: CANWARD surveillance study // Antimicrob. Agents Chemother. 2012. Vol. 56 (3). P. 1247–1252. doi: 10.1128/AAC.05823-11.
7. Katsandri A., Papaparaskevas J., Pantazatou A., Petrikkos G.L., Thomopoulos G., Houhoula D.P., Avlamis A. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains // J. Clin. Microbiol. 2006. Vol. 44 (9). P. 3465–3467.
8. Mory F., Carlier J.P., Alauzet C., Thouvenin M., Schuhmacher H., Lozniewski A. Bacteremia caused by a metronidazole-resistant Prevotella sp. Strain // J. Clin. Microbiol. 2005. Vol. 43 (10). P. 5380–5383.
9. Nagy E., Maier T., Urban E., Terhes G., Kostrzewa M., ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry // Clin. Microbiol. Infect. 2009. Vol. 15 (8). P. 796–802. doi: 10.1111/j.14690691.2009.02788.x.
10. Nagy E., Urban E., Nord C.E.; ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience // Clin. Microbiol. Infect. 2011. Vol. 17(3). P. 371–379. doi: 10.1111/j.14690691.2010.03256.x.
11. Rennie R.P., Turnbull L., Brosnikoff C., Cloke J. First comprehensive evaluation of the M.I.C. evaluator device compared to Etest and CLSI reference dilution methods for antimicrobial susceptibility testing of clinical strains of anaerobes and other fastidious bacterial species // J. Clin. Microbiol. 2012. Vol. 50 (4). P. 1153-1157. doi: 10.1128/JCM.05397-11.
12. Snydman D.R., Jacobus N.V., McDermott L.A., Golan Y., Hecht D.W., Golgstein E.J., Harrell L., Jenkins S., Newton D., Pierson C., Rihs J.D., Yu V.L., Venezia R., Finegold S.M., Rosenblatt J.E., Gorbach S.L. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005–2007) // Clin. Infect. Dis. 2010. Vol. 50. Suppl 1. P. 26–33. doi: 10.1086/647940.
13. Turner P., Edwards R., Weston V., Gazis A., Ispahani P., Greenwood D. Simultaneous resistance to metronidazole, co-amoxiclav and imipenem in clinical isolate of Bacteroides fragilis // Lancet. 1995. Vol. 345 (8960). P. 1275–1277.
14. Wexler H.M. Bacteroides: the good, the bad and the nitty-gritty // Clin. Microbiol. Rev. 2007. Vol. 20 (4). P. 593–621.
15. Wybo I., Soetens O., De Bel A., Echahidi F., Vancutsem E., Vandoorslaer K., Pierard D. Species identification of clinical Prevotella isolates by matrix-assisted laser-desorption ionization-time of flight mass spectrometry // J. Clin. Microbiol. 2012. Vol. 50 (4). P. 1415–1418. doi: 10.1128/JCM.06326-11.
Review
For citations:
Shilnikova I.I., Dmitrieva N.V. EVALUATION OF ANTIBIOTIC SUSCEPTIBILITY OF ANAEROBIC PATHOGENS BACTEROIDES, PREVOTELLA AND FUSOBACTERIUM ISOLATED FROM CANCER PATIENTS. Siberian journal of oncology. 2015;1(5):37-43. (In Russ.)
Views:
1771
Email this article 
